BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright ©The Author(s) 2026.
World J Psychiatry. Jan 19, 2026; 16(1): 113064
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.113064
Table 1 The inclusion criteria and exclusion criteria of each group
Group
Inclusion criteria
Exclusion criteria
MDD-OB(1) Outpatients meeting DSM-5 diagnostic criteria for MDD, with current MDE confirmed through the M.I.N.I 5.0 by trained psychiatrists; (2) HAMD-24 score ≥ 20; (3) First-episode, antidepressant-naive status at enrollment; and (4) BMI1 ≥ 28 kg/m2(1) Presence of organic brain diseases; (2) Severe systemic diseases; (3) Intellectual disability (or: Mental retardation); (4) History of alcohol or substance abuse; (5) Visual or auditory impairments; (6) History of clinically diagnosed neurological disorders; and (7) Pregnant or lactating women
MDD(1) Outpatients meeting DSM-5 diagnostic criteria for MDD, with current MDE confirmed through the M.I.N.I 5.0 by trained psychiatrists; (2) HAMD-24 score ≥ 20; (3) First-episode, antidepressant-naive status at enrollment; and (4) 18.5 ≤ BMI < 24 kg/m2
OB(1) BMI ≥ 28 kg/m2; and (2) Exclusion of MDD and other conditions meeting exclusion criteria
HC(1) 18.5 ≤ BMI < 24 kg/m2; and (2) Exclusion of MDD and other conditions meeting exclusion criteria
All participant groups(1) Minimum education level: Completion of elementary school or higher; (2) Aged 18-60 years, irrespective of gender; and (3) Voluntary participation with written informed consent obtained after full explanation of study procedures
Table 2 Demographic features of participants in the study, n (%)
Variables
HC (n = 37)
OB (n = 42)
MDD (n = 47)
MDD-OB (n = 23)
F/χ2
P value
Post-hoc analysis
Age40.92 (8.61)38.6 (9.21)38.11 (12.99)34 (11.02)2.100.104
Sex (male/female)14/2323/1923/247/165.020.171
BMI23.24 (2.12)30.96 (2.48)22.36 (2.97)33.14 (8.85)61.01< 0.001OB > HC, MDD; MDD-OB > HC, OB, MDD-OB
HAMD-241.946 (2.95)4.048 (6.77)29.617 (11.33)26.08 (14.101)93.83< 0.001MDD > HC, OB; MDD-OB > HC, OB
Behavioral activation/inhibition
BASR12.81 (1.74)13.41 (1.68)11.51 (2.59)12.22 (1.91)6.51< 0.001HC > MDD; OB > MDD, MDD-OB
BASD11.39 (2.20)17.41 (1.70)15.51 (2.23)15.87 (2.88)49.52< 0.001OB > HC, MDD, MDD-OB; MDD > HC; MDD-OB > HC
BASF14.28 (2.54)20.03 (2.07)18.33 (2.58)19.35 (2.37)40.32< 0.001OB > HC, MDD; MDD > HC; MDD-OB > HC
BIS14.44 (2.01)19.82 (2.42)20.11 (3.39)21.04 (2.23) 43.15< 0.001OB > HC; MDD > HC; MDD-OB > HC
Mean FD_Jenkinson10.8 (0.04)0.11 (0.07)0.09 (0.06)0.11 (0.06)2.100.102
Table 3 Brain areas with significantly different regional homogeneity values among healthy control, obesity, major depressive disorder, and comorbid major depressive disorder-obesity groups
Brain
Peak MNI Coordinates
F
Cluster size
X
Y
Z
MTG.L-57-39024.6759
Cuneus.R3-843628.3936
Precuneus.L-6-784529.650
Thalamus.L-15-27025.0526